Valtteri Kaasinen

Valtteri Kaasinen

Auto-generated profile, based on publicly available information

Valtteri Kaasinen

Clinical Neurosciences, University of Turku, Turku, Finland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Neurobiology of Aging
Verified
Journal Article
Closed access
VKV Kaasinen
V Kaasinen
HVH Vilkman
H Vilkman
JHJ Hietala
J Hietala
KNK Någren
K Någren
HHH Helenius
H Helenius
JRJ Rinne
J Rinne

1 October 2004 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
ABA Bruck
A Bruck
TKT Kurki
T Kurki
VKV Kaasinen
V Kaasinen
TVT Vahlberg
T Vahlberg
JRJ O Rinne
J O Rinne
Background: Early stage patients with Parkinson’s disease (PD) show cognitive impairment in frontal lobe functions and memory tests. Hippocampal atrophy is seen in medicated patients with advanced PD. Objectives: To examine whether prefrontal or hippocampal atrophy are already present in early stage PD, and whether such atrophy is associated with cognitive impairment. Methods: Twenty non-medicated, non-demented patients with early stage PD and 22 neurologically healthy age matched controls were studied. All subjects underwent magnetic resonance imaging to study hippocampal and prefrontal atrophy. Atrophy was evaluated by a neuroradiologist using a five point scale. In addition, the patients underwent a neuropsychological test battery sensitive to frontal lobe functions and memory. Results: Patients with PD had atrophy in the right and the left prefrontal cortex. In the right hippocampus, the mean atrophy score was 1.15 in PD and 0.45 in controls. Corresponding figures for the left hippocampus were 1.05 for PD and 0.64 for controls. In PD, the left hippocampus atrophy correlated with verbal memory and prefrontal atrophy correlated with impaired performance in a test measuring vigilance. Conclusions: Non-medicated, non-demented patients with early stage PD show hippocampal and prefrontal atrophy. Impaired memory is related to hippocampal atrophy, whereas sustained attention is related to prefrontal atrophy.

1 February 2001 in Pain
Verified
Journal Article
Closed access
SJSatu K. Jääskeläinen
Satu K. Jääskeläinen
JRJuha O. Rinne
Juha O. Rinne
HFHeli Forssell
Heli Forssell
OTOlli Tenovuo
Olli Tenovuo
VKValtteri Kaasinen
Valtteri Kaasinen
JBJörgen Bergman
Jörgen Bergman
Recent data from animal experiments suggest an important role for the basal ganglia in the processing and sensorimotor gating of nociceptive information. However, very little is known about their possible participation in human pain. Because of our previous finding of increased excitability of the blink reflex (a brainstem reflex under dopaminergic inhibitory control) in some burning mouth syndrome (BMS) patients, we have studied the dopaminergic function of the striatum (putamen and caudatus) of BMS patients with positron emission tomography (PET). 6-[(18)F]fluorodopa (FDOPA) PET scans were done on ten BMS patients and 14 healthy control subjects. The presynaptic dopaminergic function was significantly decreased in the right putamen (20%, P=0.04) of the BMS patients compared to control subjects. On the left side, the FDOPA uptake was decreased by 17% (P=0.08). The mean FDOPA uptake was not significantly changed in the caudate nucleus of the patients. The finding of decreased striatal FDOPA uptake in the putamen supports our previous neurophysiological observations indicating decreased dopaminergic inhibition in BMS patients. The present result provides direct evidence of the involvement of the nigrostriatal dopaminergic system in pain for the first time in a clinical pain condition.

1 November 2002 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
VKValtteri Kaasinen
Valtteri Kaasinen
JRJuha O Rinne
Juha O Rinne

1 August 2014 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JJJuho Joutsa
Juho Joutsa
MGMaria Gardberg
Maria Gardberg
MRMatias Röyttä
Matias Röyttä
VKValtteri Kaasinen
Valtteri Kaasinen

1 August 2020 in NeuroImage
Verified
Journal Article
Open access
TKTatu Kantonen
Tatu Kantonen
TKTomi Karjalainen
Tomi Karjalainen
JIJanne Isojärvi
Janne Isojärvi
PNPirjo Nuutila
Pirjo Nuutila
JTJouni Tuisku
Jouni Tuisku
LNLauri Nummenmaa
Lauri Nummenmaa
Alterations in the brain's μ-opioid receptor (MOR) system have been associated with several neuropsychiatric disorders. Central MOR availability also varies considerably in healthy individuals. Multiple epidemiological factors have been proposed to influence the MOR system, but due to small sample sizes the magnitude of their influence remains inconclusive. We compiled [11C]carfentanil positron emission tomography scans from 204 individuals with no neurologic or psychiatric disorders, and estimated the effects of sex, age, body mass index (BMI) and smoking on [11C]carfentanil binding potential using between-subject regression analysis. We also examined hemispheric differences in MOR availability. Older age was associated with increase in MOR availability in frontotemporal areas but decrease in amygdala, thalamus, and nucleus accumbens. The age-dependent increase was stronger in males. MOR availability was globally lowered in smokers but independent of BMI. Finally, MOR availability was higher in the right versus the left hemisphere. The presently observed variation in MOR availability may explain why some individuals are prone to develop MOR-linked pathological states, such as chronic pain or psychiatric disorders. Lateralized MOR system may reflect hemispheric work specialization in central emotion and pain processes.